TrialThrombosis and haemostasis2008

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.

Wolfgang Mueck et al.PubMed ↗

No numbers read from the abstract.